Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens

被引:51
作者
Hattori, Y [1 ]
Tashiro, H [1 ]
Kawamoto, T [1 ]
Kodama, Y [1 ]
机构
[1] UNIV OCCUPAT & ENVIRONM HLTH,DEPT ENVIRONM HLTH,YAHATANISHI KU,KITAKYUSHU,FUKUOKA 807,JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1995年 / 86卷 / 12期
关键词
serum pepsinogen; gastric cancer; mass screening; sensitivity and specificity;
D O I
10.1111/j.1349-7006.1995.tb03317.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test), The study subjects were 4876 workers aged from 40 to 61 years old, Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measured at the same time. PG I < 50 ng/ml and PG I/PG II ratio < 3.0 were adopted as the criteria for a positive result for the PG test. PG test-positive subjects were examined, in principle, by endoscopy. Furthermore, all the subjects were followed up for a year to check for occurrence of gastric cancer, Among the total subjects, 911 (18.7%) were positive for the PG test and 650 (71.4%) among the positive subjects underwent further examinations, which revealed 11 cases of gastric cancer. Seven gastric cancer cases were diagnosed during the follow-up period within one year after the PG test. Six out of the 7 cancer cases had been negative in the PG test, When the results of one year's follow-up from the time of screening were defined as the gold standard, the sensitivity and specificity of the PG test were estimated at 66.7% and 81.5%, respectively, The authors conclude that the validity of the PG test as a mass screening method may be comparable to that of X-ray screening, if optimum criteria of a positive test are selected.
引用
收藏
页码:1210 / 1215
页数:6
相关论文
共 46 条
[1]  
AOKI K, 1992, JPN MED J, V3576, P43
[2]   SERUM PEPSINOGEN LEVEL WITH SPECIAL REFERENCE TO HISTOLOGY OF GASTRIC MUCOSA [J].
BOCK, OAA ;
ARAPAKIS, G ;
WITTS, LJ ;
RICHARDS, WC .
GUT, 1963, 4 (02) :106-+
[3]   UICC WORKSHOP OF THE PROJECT ON EVALUATION OF SCREENING PROGRAMS FOR GASTROINTESTINAL CANCER - MEETING HELD IN GOTHENBURG, SWEDEN, ON NOVEMBER 4-6, 1985 [J].
CHAMBERLAIN, J ;
DAY, NE ;
HAKAMA, M ;
MILLER, AB ;
PROROK, PC .
INTERNATIONAL JOURNAL OF CANCER, 1986, 37 (03) :329-334
[4]   CLINICAL AND STATISTICAL FOLLOW-UP STUDY OF ATROPHIC GASTRITIS [J].
CHELI, R ;
SANTI, L ;
CIANCAMERLA, G ;
CANCIANI, G .
AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1973, 18 (12) :1061-1066
[5]  
COLE P, 1980, JNCI-J NATL CANCER I, V64, P1263
[6]  
CORREA P, 1983, CANCER SURV, V2, P437
[7]   CORRELATION BETWEEN THE PREVALENCE OF GASTRITIS AND GASTRIC-CANCER IN JAPAN [J].
FUKAO, A ;
HISAMICHI, S ;
OHSATO, N ;
FUJINO, N ;
ENDO, N ;
IHA, M .
CANCER CAUSES & CONTROL, 1993, 4 (01) :17-20
[8]  
Fukao A, 1992, J GASTROENTEROL MASS, V97, P59
[9]  
HARUKI K, 1993, GASTROENTEROL JPN, V28, P359
[10]  
HOWSON CP, 1986, EPIDEMIOL REV, V8, P1